Showing results (421-430 of 1,020) with videos related to
Sort By:
Pageof 102
Cancer Biotherapy & Radiopharmaceuticals|September 5, 2003
Chimeric TNT-3/human beta-glucuronidase fusion proteins for antibody-directed enzyme prodrug therapy (ADEPT)Barbara H Biela, Leslie A Khawli, Peisheng Hu, et al.The Journal of Investigative Dermatology|May 1, 1978
Effects of 4-tertiary butyl catechol on tissue cultured melanocytesJ D Mansur, K Fukuyama, G A Gellin, et al.Annals of the New York Academy of Sciences|January 1, 1983
Idiotypes of anti-major histocompatibility complex antibodiesD H Sachs, J A Bluestone, S L Epstein, et al.Investigative Ophthalmology & Visual Science|January 8, 2010
Modulation of inflammatory markers by miR-146a during replicative senescence in trabecular meshwork cellsGuorong Li, Coralia Luna, Jianming Qiu, et al.Journal of Experimental Psychology. Human Perception and Performance|August 8, 2020
The outlier paradox: The role of iterative ensemble coding in discounting outliersMichael L Epstein, Jake Quilty-Dunn, Eric Mandelbaum, et al.Cancer|March 15, 1988
Heterogeneity among the non-Hodgkin's lymphomas. Implications for autologous bone marrow transplantation with in vitro purging using monoclonal antibodiesJ N Winter, R J Marder, B Mankad, et al.Cellular Immunology|April 15, 1991
Macrophage chemotactic factor partially purified from granulomatous inflammationY Sasaki, T Iida, N Sato, et al.Cytotechnology|November 13, 2008
Cell engineering for muscle gene therapy: Extemporaneous production of retroviral vector packaging macrophages using defective herpes simplex virus type 1 vectors harbouring gag, pol, env genesE Parrish, E Peltékian, G Dickson, et al.Leukemia Research|January 1, 1989
The elimination of malignant B lymphocytes from human bone marrow using monoclonal antibodies DLC-48 and LN-1 and human serum: a preclinical studyJ N Winter, A L Epstein, B Bass, et al.Chemical & Pharmaceutical Bulletin|July 1, 1989
Partial purification and characterization of epidermal plasminogen activator and their inhibitorM Nakagawa, K Fukuyama, W L Epstein, et al.Pageof 102